Could have been the best opportunity for those looking at averaging down. We may have just past it. Still not too bad at all.
2024 One of ASX stock to watch. - APX
- Forums
- ASX - By Stock
- APX
- Ann: Customer update and FY23 preliminary results
Ann: Customer update and FY23 preliminary results, page-225
-
- There are more pages in this discussion • 170 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add APX (ASX) to my watchlist
|
|||||
Last
50.0¢ |
Change
-0.005(0.99%) |
Mkt cap ! $111.5M |
Open | High | Low | Value | Volume |
51.0¢ | 53.0¢ | 49.0¢ | $1.034M | 2.032M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 25178 | 50.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.0¢ | 26979 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 25178 | 0.500 |
4 | 52371 | 0.495 |
15 | 360117 | 0.490 |
7 | 101980 | 0.485 |
10 | 470902 | 0.480 |
Price($) | Vol. | No. |
---|---|---|
0.510 | 26979 | 3 |
0.515 | 15117 | 2 |
0.520 | 73197 | 6 |
0.525 | 20811 | 2 |
0.530 | 140339 | 6 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
APX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online